RedCarpetLife
2043
In the world , as of 27 Nov 2025
Rajendra Agarwal

Rajendra Agarwal

R. Agarwal
$1.87 B ₹ 17,198 Cr
Real Time Net Worth #2043 Ranking as of 27 Nov 2025 By Forbes

More on Rajendra Agarwal

Gender

Male

Age

66Y

Country

India

Born On

January, 1960

Deceased

No

Relationship Status

Unknown

Children

Unknown

Education

Unknown

Designation Info :

Self-Made

Yes

Entrepreneur Type

Self-Made (Pharmaceuticals)

Primary Organization

Macleods Pharmaceuticals

Titles

Co-Founder

Sources of Wealth

Macleods Pharmaceuticals

Industry

Pharmaceuticals, Healthcare

About Rajendra Agarwal


R ajendra Agarwal is an Indian billionaire who is a co-founder of the Macleods Pharmaceuticals company. He and his two brothers, Girdhari Lal Bawri and Banwari Lal Bawri, founded the company in 1986. They have since built Macleods into one of India's largest privately held pharmaceutical companies. The company has a strong focus on producing generic drugs for a wide range of therapeutic areas, particularly in the treatment of infectious diseases like tuberculosis.

Macleods is a major supplier of anti-TB drugs to the World Health Organization. The company has a large and successful business in exporting its generic drugs to markets around the world, in addition to its strong presence in the Indian domestic market. The three brothers share ownership of the highly successful and profitable pharmaceutical enterprise, which has made them all billionaires. The company remains privately held by the founding families.

Advertisement

Quick Reads


  • Co-founder of the Indian generic drugmaker Macleods Pharmaceuticals.
  • He and his two brothers founded the company in 1986.
  • The company is a major producer of anti-tuberculosis drugs.
  • Macleods is a major supplier to the World Health Organization.
  • The company is one of India's largest privately held pharma companies.

Early Life and Background


Rajendra Agarwal is an Indian businessman, the self-made billionaire Executive and a major shareholder of Macleods Pharmaceuticals Ltd., a major global manufacturer of generic drugs and APIs (Active Pharmaceutical Ingredients). His career is rooted in pharmaceuticals, science, and entrepreneurial audacity.

Agarwal's career is defined by his long-term executive leadership in the global generic drug sector. His structural role is tied to the successful development of high-volume drug manufacturing and the company's commitment to providing affordable, quality medicines to the massive domestic and international consumer base.

  • Macleods Pharmaceuticals (Executive & Shareholder): The core private asset, a major global manufacturer of generic drugs and APIs (specializing in anti-malarial, anti-tuberculosis, and cardiovascular drugs).
  • Pharmaceutical Focus: His success is built on scale manufacturing and R&D in essential therapeutic areas (a key structural role in the global pharmaceutical supply chain).
  • Family Governance: He and his brothers control the massive private empire.
  • Investment Strategy: His philosophy is rooted in long-term investment in industrial assets and leveraging the massive Indian pharmaceutical growth story (the global generic drug hub).

Career Journey of Rajendra Agarwal


Rajendra Agarwal's strategic leadership involves managing the continuous manufacturing and R&D for high-quality drugs within the Macleods Pharmaceuticals empire. His structural contribution is immense: pioneering the scale manufacturing and professionalization of the Indian generic drug sector, making India a major global source of affordable medicines.

His wealth is secured by the colossal, long-term, stable profitability of the global generic drug and healthcare sector.

Advertisement

Rajendra Agarwal's Timeline


1990s (approx.):

Macleods Pharmaceuticals is founded (Founding).

2000s (approx.):

Rajendra Agarwal assumes an executive role in the company (Executive Ascent).

Ongoing:

Macleods expands aggressively into international markets (Global Apex).

Ongoing:

Continues as key executive and shareholder, guiding the global pharmaceutical giant (Executive Oversight).

Major Business Ventures and Investments


Rajendra Agarwal's wealth is concentrated in his equity stake and continued executive leadership role in the private pharmaceutical giant, Macleods Pharmaceuticals Ltd., and his private investments.

  • Macleods Pharmaceuticals (Executive & Shareholder): The core private asset, a major global manufacturer of generic drugs and APIs (specializing in anti-malarial, anti-tuberculosis, and cardiovascular drugs).
  • Pharmaceutical Focus: His success is built on scale manufacturing and R&D in essential therapeutic areas (a key structural role in the global pharmaceutical supply chain).
  • Family Governance: He and his brothers control the massive private empire.
  • Investment Strategy: His philosophy is rooted in long-term investment in industrial assets and leveraging the massive Indian pharmaceutical growth story (the global generic drug hub).

Advertisement

Philanthropy and Social Impact


Rajendra Agarwal's social impact is structural, stemming from Macleods Pharmaceuticals' role in providing essential, affordable generic drugs and APIs to millions globally. The company contributes significantly to global public health by pioneering affordable treatments for diseases like tuberculosis and malaria. His personal philanthropy supports various community and educational initiatives.

His structural contribution is tied to the successful industrialization and scale of the Indian pharmaceutical sector.

Fashion, Style, and Lifestyle


Rajendra Agarwal maintains the professional, composed style of an industrial executive. His attire is consistently formal and high-quality, favoring tailored business suits or traditional Indian business attire. His aesthetic reflects serious authority and stability, typical of a leader in the specialized pharmaceutical sector.

Residing in Mumbai, India, his luxury is the immense security and financial reward derived from his multi-billion dollar fortune. His life is dedicated to industrial scale, quality control, and the long-term, stable growth of the pharmaceutical supply chain.

Advertisement

Quotes and Philosophy


No publicly available quotes.

Fun Facts & Trivia


  • He is an executive and major shareholder of Macleods Pharmaceuticals (generic drugs and APIs).
  • Macleods is a major global supplier of anti-tuberculosis and anti-malarial drugs.
  • His fortune is tied to the successful monetization of the Indian generic drug revolution.
  • His company is known for its focus on affordability for the domestic and global mass market.
  • He and his brothers control the massive private empire.
  • His wealth is estimated at $2.5 billion (2024 estimate).
  • His philosophy emphasizes scale manufacturing and cost efficiency.

Advertisement

More Profiles


Peter Thomson

+6.81% | +$405.00M

Maggie Hardy

+19.38% | +$702.23M

You May Like


Sources & References


This profile is compiled from verified biographical and financial records:

  • Wealth Data: Real-time tracking and historical data from Forbes Billionaires and the Bloomberg Billionaires Index.
  • Biographical Records: Educational and career history sourced from Reuters, The Wall Street Journal, and official university alumni directories.
  • Regulatory Filings: Shareholder and executive disclosures from stock exchange databases, including HKEX, SSE, SZSE, and SEC EDGAR.
  • Corporate History: Primary data from annual company reports, founding charters, and verified press announcements.

All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.

If you find any inaccuracies, please report them to admin@redcarpetlife.in

Sponsored Content